Data / Form D filings / Biofrontera Inc.
Biofrontera Inc.: Form D filings
Biofrontera Inc., a pharmaceuticals company in Woburn, MA, filed 7 Form D notices with the SEC between 2021 and 2025. The latest, on July 11, 2025, reports $11 million sold of a $11 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 120 PRESIDENTIAL WAY, SUITE 330, Woburn, MA, 01801
- Phone
- (781) 245-1325
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1858685
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 11, 2025 | New notice | $11,000,000 | $11,000,000 | 5 | Jun 27, 2025 | sec.gov | |
| Dec 5, 2024 | New notice | $4,200,000 | $4,200,000 | 5 | Nov 21, 2024 | sec.gov | |
| Mar 5, 2024 | New notice | $8,000,000 | $8,000,000 | 8 | Feb 19, 2024 | sec.gov | |
| Nov 4, 2022 | New notice | $3,683,209 | $3,683,209 | 1 | Oct 25, 2022 | sec.gov | |
| Aug 11, 2022 | New notice | $7,114,287 | $7,114,287 | 1 | Jul 27, 2022 | sec.gov | |
| May 23, 2022 | New notice | $9,400,681 | $9,400,681 | 1 | May 16, 2022 | sec.gov | |
| Dec 10, 2021 | New notice | $15,000,000 | $15,000,000 | 1 | Nov 29, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Beth J. Hoffman | Director | |
| John J. Borer III | Director | |
| Hermann Luebbert | Executive Officer, Director | |
| Eugene Frederick Leffler, III | Executive Officer | |
| Heikki J. Lanckriet | Director | |
| Kevin D. Weber | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jul 7, 2025 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Biofrontera Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.